Name
premar2
Label
Premarin (Conjugated Estrogens) (SHHS2)
Description

Participant taking PREMARIN (CONJUGATED ESTROGENS) within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Premarin (Conjugated Estrogens) (SHHS2) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total - 4,080 -
No - 3,197 -
Yes - 423 -
Unknown - 460 -
Premarin (Conjugated Estrogens) (SHHS2) vs Age at SHHS1
Visit 2
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 184 707 1,321 1,200 624 44 4,080
No 169 547 976 962 505 38 3,197
Yes 7 100 172 94 48 2 423
Unknown 8 60 173 144 71 4 460
Premarin (Conjugated Estrogens) (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,660 1,537 3,197
Yes 1 422 423
Unknown 200 260 460
Premarin (Conjugated Estrogens) (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 2,776 230 191 3,197
Yes 386 12 25 423
Unknown 425 14 21 460